Enzo Biochem (ENZ) Appoints Steven J. Pully to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
October 30, 2023 4:15 PM EDTFARMINGDALE, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Â Enzo Biochem, Inc. (NYSE: ENZ) (Enzo or the Company), a leading life sciences company, announced today that Steven J. Pully has been appointed to the Companys Board of Directors effective October 26, 2023. Mr. Pully will assume the role of Chairperson of the Board, and Chair of the Audit Committee as well.
In 2023, Enzo completed the divestiture of Enzo Clinical Labs, Inc. and focused its strategy on growing the life sciences division, said Kara Cannon, Enzos Chief Executive Officer. Steve brings a unique portfolio of legal, corporate governance, and financial... More
